Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Shares Issued (2021 - 2025)

PAVmed (PAVM) has 5 years of Shares Issued data on record, last reported at $841000.0 in Q1 2025.

  • For Q1 2025, Shares Issued rose 1256.45% year-over-year to $841000.0; the TTM value through Sep 2025 reached $899000.0, changed N/A, while the annual FY2024 figure was $62000.0, 95.96% down from the prior year.
  • Shares Issued reached $841000.0 in Q1 2025 per PAVM's latest filing, up from $58000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $7.7 million in Q4 2021 and bottomed at -$891000.0 in Q3 2023.
  • Average Shares Issued over 5 years is $773533.3, with a median of $182000.0 recorded in 2023.
  • The widest YoY moves for Shares Issued: up 2162.3% in 2023, down 446.63% in 2023.
  • A 5-year view of Shares Issued shows it stood at $7.7 million in 2021, then plummeted by 100.79% to -$61000.0 in 2022, then soared by 2162.3% to $1.3 million in 2023, then tumbled by 95.39% to $58000.0 in 2024, then surged by 1350.0% to $841000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $841000.0 in Q1 2025, $58000.0 in Q4 2024, and $922000.0 in Q2 2024.